Waldencast plc (WALD)
After hours:
| Previous close | 5.21 |
| Open | 5.34 |
| Bid | 4.95 x 100 |
| Ask | 5.27 x 100 |
| Day's range | 5.04 - 5.40 |
| 52-week range | 5.00 - 12.00 |
| Volume | |
| Avg. volume | 74,944 |
| Market cap | 622.588M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.18 |
| Earnings date | 21 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.00 |
GlobeNewswireWaldencast Regains Compliance with Nasdaq Filing Requirements
WHITE PLAINS, N.Y., March 25, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that on March 21, 2024 the Company received formal notice from the Nasdaq Hearings Panel (the “Panel”) confirming that it has regained compliance with Nasdaq’s filing requirements, as set forth in Nasdaq Listing Rule 5250(c) (the “Periodic Filing Rule”) following the filing of the Company’s financial results for the interim period ende
- GlobeNewswire
Waldencast Reports First Half 2023 Results
— H1’23 Total Net Revenue of $109.3 million— H1’23 Combined Adjusted EBITDA of $13.9 million up from $7.6 million in H1’22— Introduces guidance WHITE PLAINS, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that it furnished its results for the interim period ended June 30, 2023 (“H1 2023 Interim Financials”) on Form 6-K to the U.S. Securities and Exchange Commission, which a
GlobeNewswireObagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream
This New Product is the Latest Introduction to Obagi’s Daily Hydro-Drops® Collection Obagi Cosmeceuticals expands Daily Hydro-Drops® portfolio Daily Hydro-Drops® Rejuvenating Eye Gel Cream and Daily Hydro-Drops® Facial Serum Daily Hydro-Drops® Rejuvenating Eye Gel Cream and Daily Hydro-Drops® Facial Serum Video LONG BEACH, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Obagi Cosmeceuticals LLC (“Obagi”), a leader in skincare innovation and the originator of medical-grade skincare and a subsidiary of
